Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8048430 Influenza hemagglutinin and neuraminidase variants

Patent 8048430 was granted and assigned to MedImmune on November, 2011 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

MedImmune

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

8048430

Patent Inventor Names

Chongguang Liu0

George Kemble0

Chin-Fen Yang0

Date of Patent

November 1, 2011

Patent Application Number

12877000

Date Filed

September 7, 2010

Patent Citations Received

‌

US Patent 12122807 Influenza virus replication for vaccine development

‌

US Patent 11802273 Mutations that confer genetic stability to additional genes in influenza viruses

‌

US Patent 11851648 Humanized cell line

‌

US Patent 12076387 Vaccines comprising mutant attenuated influenza viruses

Patent Primary Examiner

‌

Mary E. Mosher

Patent abstract

Polypeptides, polynucleotides, methods, compositions, and vaccines comprising influenza hemagglutinin and neuraminidase variants are provided.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8048430 Influenza hemagglutinin and neuraminidase variants

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API